Article
Comprehensive study of nine novel cases of TFEB ‐amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression
14 May 2022
Abstract excerpt
AIMS: First described in 2014, renal cell carcinoma (RCC) with TFEB amplification (6p21) is a rare molecular subgroup whose diagnosis is challenging. The prognosis and therapeutic implications remain unclear. METHODS: We report here the clinical, histological, immunohistochemical, and genetic features of nine novel cases. The pathological and immunohistochemical features were centrally reviewed by expert...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
